tri agonist glp 1 Effects of site-directed mutagenesis of GLP-1 and glucagon receptors on signal transduction activated by dual and triple agonists Triple G" (2/4) With tirzepatide

Description

For people who need long-term weight management , tirzepatide offers something phentermine cannot: sustained effectiveness over months and years of continuous use

Given their effectiveness in controlling blood glucose and HbA1c levels, with additional weight loss benefits and minimal intrinsic risk of hypoglycemic episodes, GLP-1 RAs are now considered the first-line injectables for optimal glucose control in diabetic patients even before insulin treatment [18]

Moving from insulin to GLP-1 A patient on basal insulin whose Type 2 diabetes is relatively well controlled might transition to a GLP-1 agonist if they are gaining excessive weight on insulin, want to simplify their regimen, have developed cardiovascular risk factors that would benefit from GLP-1 protection, or have adequate remaining beta cell function

Certain individualssuch as those with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2should not use GLP-1 receptor agonists